Influenza Diagnostics Industry Research Report 2024

February 2024 | 86 pages | ID: I9789492EF26EN
APO Research

Abstracts

This report aims to provide a comprehensive presentation of the global market for Influenza Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Diagnostics.

The Influenza Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Diagnostics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Influenza Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

• BD
• Abbott (Include Alere)
• Roche
• SIEMENS
• Analytik Jena
• Quidel
• Thermo Fisher
• Meridian Bioscience
• BioMerieux
• Sekisui Diagnostics
• Response Biomedical
• SA Scientific

Product Type Insights

Global markets are presented by Influenza Diagnostics type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Influenza Diagnostics are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).

Influenza Diagnostics segment by Type

• RIDT
• RT-PCR
• Cell Culture
• Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).

This report also outlines the market trends of each segment and consumer behaviors impacting the Influenza Diagnostics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Influenza Diagnostics market.

Influenza Diagnostics Segment by Application

• Hospitals
• POCT
• Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Influenza Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Influenza Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Influenza Diagnostics industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Diagnostics.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Influenza Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

Contents

1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Influenza Diagnostics by Type
  2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
  1.2.2 RIDT
  1.2.3 RT-PCR
  1.2.4 Cell Culture
  1.2.5 Others
2.3 Influenza Diagnostics by Application
  2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
  2.3.2 Hospitals
  2.3.3 POCT
  2.3.4 Others
2.4 Assumptions and Limitations

3 INFLUENZA DIAGNOSTICS BREAKDOWN DATA BY TYPE

3.1 Global Influenza Diagnostics Historic Market Size by Type (2019-2024)
3.2 Global Influenza Diagnostics Forecasted Market Size by Type (2025-2030)

4 INFLUENZA DIAGNOSTICS BREAKDOWN DATA BY APPLICATION

4.1 Global Influenza Diagnostics Historic Market Size by Application (2019-2024)
4.2 Global Influenza Diagnostics Forecasted Market Size by Application (2019-2024)

5 GLOBAL GROWTH TRENDS

5.1 Global Influenza Diagnostics Market Perspective (2019-2030)
5.2 Global Influenza Diagnostics Growth Trends by Region
  5.2.1 Global Influenza Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
  5.2.2 Influenza Diagnostics Historic Market Size by Region (2019-2024)
  5.2.3 Influenza Diagnostics Forecasted Market Size by Region (2025-2030)
5.3 Influenza Diagnostics Market Dynamics
  5.3.1 Influenza Diagnostics Industry Trends
  5.3.2 Influenza Diagnostics Market Drivers
  5.3.3 Influenza Diagnostics Market Challenges
  5.3.4 Influenza Diagnostics Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Influenza Diagnostics Players by Revenue
  6.1.1 Global Top Influenza Diagnostics Players by Revenue (2019-2024)
  6.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2019-2024)
6.2 Global Influenza Diagnostics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Influenza Diagnostics Head office and Area Served
6.4 Global Influenza Diagnostics Players, Product Type & Application
6.5 Global Influenza Diagnostics Players, Date of Enter into This Industry
6.6 Global Influenza Diagnostics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Influenza Diagnostics Market Size (2019-2030)
7.2 North America Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Influenza Diagnostics Market Size by Country (2019-2024)
7.4 North America Influenza Diagnostics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Influenza Diagnostics Market Size (2019-2030)
8.2 Europe Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Influenza Diagnostics Market Size by Country (2019-2024)
8.4 Europe Influenza Diagnostics Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Influenza Diagnostics Market Size (2019-2030)
9.2 Asia-Pacific Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Influenza Diagnostics Market Size by Country (2019-2024)
9.4 Asia-Pacific Influenza Diagnostics Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Influenza Diagnostics Market Size (2019-2030)
10.2 Latin America Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Influenza Diagnostics Market Size by Country (2019-2024)
10.4 Latin America Influenza Diagnostics Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Influenza Diagnostics Market Size (2019-2030)
11.2 Middle East & Africa Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Influenza Diagnostics Market Size by Country (2019-2024)
11.4 Middle East & Africa Influenza Diagnostics Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 BD
  11.1.1 BD Company Detail
  11.1.2 BD Business Overview
  11.1.3 BD Influenza Diagnostics Introduction
  11.1.4 BD Revenue in Influenza Diagnostics Business (2017-2022)
  11.1.5 BD Recent Development
11.2 Abbott (Include Alere)
  11.2.1 Abbott (Include Alere) Company Detail
  11.2.2 Abbott (Include Alere) Business Overview
  11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
  11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2017-2022)
  11.2.5 Abbott (Include Alere) Recent Development
11.3 Roche
  11.3.1 Roche Company Detail
  11.3.2 Roche Business Overview
  11.3.3 Roche Influenza Diagnostics Introduction
  11.3.4 Roche Revenue in Influenza Diagnostics Business (2017-2022)
  11.3.5 Roche Recent Development
11.4 SIEMENS
  11.4.1 SIEMENS Company Detail
  11.4.2 SIEMENS Business Overview
  11.4.3 SIEMENS Influenza Diagnostics Introduction
  11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2017-2022)
  11.4.5 SIEMENS Recent Development
11.5 Analytik Jena
  11.5.1 Analytik Jena Company Detail
  11.5.2 Analytik Jena Business Overview
  11.5.3 Analytik Jena Influenza Diagnostics Introduction
  11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2017-2022)
  11.5.5 Analytik Jena Recent Development
11.6 Quidel
  11.6.1 Quidel Company Detail
  11.6.2 Quidel Business Overview
  11.6.3 Quidel Influenza Diagnostics Introduction
  11.6.4 Quidel Revenue in Influenza Diagnostics Business (2017-2022)
  11.6.5 Quidel Recent Development
11.7 Thermo Fisher
  11.7.1 Thermo Fisher Company Detail
  11.7.2 Thermo Fisher Business Overview
  11.7.3 Thermo Fisher Influenza Diagnostics Introduction
  11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2017-2022)
  11.7.5 Thermo Fisher Recent Development
11.8 Meridian Bioscience
  11.8.1 Meridian Bioscience Company Detail
  11.8.2 Meridian Bioscience Business Overview
  11.8.3 Meridian Bioscience Influenza Diagnostics Introduction
  11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2017-2022)
  11.8.5 Meridian Bioscience Recent Development
11.9 BioMerieux
  11.9.1 BioMerieux Company Detail
  11.9.2 BioMerieux Business Overview
  11.9.3 BioMerieux Influenza Diagnostics Introduction
  11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2017-2022)
  11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
  11.10.1 Sekisui Diagnostics Company Detail
  11.10.2 Sekisui Diagnostics Business Overview
  11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
  11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2017-2022)
  11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
  11.11.1 Response Biomedical Company Detail
  11.11.2 Response Biomedical Business Overview
  11.11.3 Response Biomedical Influenza Diagnostics Introduction
  11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2017-2022)
  11.11.5 Response Biomedical Recent Development
11.12 SA Scientific
  11.12.1 SA Scientific Company Detail
  11.12.2 SA Scientific Business Overview
  11.12.3 SA Scientific Influenza Diagnostics Introduction
  11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2017-2022)
  11.12.5 SA Scientific Recent Development

13 REPORT CONCLUSION

14 DISCLAIMER